REGENER-EYES® INDEPENDENT STUDIES

Explore Regener-Eyes® Independent Studies, featuring insights from independent research conducted by Eye Care Professionals. Please note that the information presented on this page originates from independent studies conducted by healthcare providers. Thank you to the professionals who provide these insights.

Please note that the independent studies showcased represent real patient outcomes submitted by healthcare professionals who have utilized Regener-Eyes®. Regener-Eyes® does not make any claims regarding the accuracy of this information.

SPOTLIGHT

“With a diverse array of tools at our disposal to address ocular surface diseases we as optometrists possess the ability to tailor treatments to the unique needs of each patient. Regener-Eyes® has proven to be an asset in my practice.” -Dr. Dámaris Raymondi, OD, FAAO
Dr. Dámaris Raymondi, OD, FAAO, published a groundbreaking independent study titled ‘Regener-Eyes® Case Study: Helping Dry Eye Associated with Sjögren's Syndrome' in Optometry Times.
During this study Dr. Raymondi explores the impact of Regener-Eyes Ophthalmic Solution on a 75-year-old patient with persistent dry eye symptoms.
READ HERE

Regener-Eyes® Independent Study: Helping Dry Eye Associated with Meibomian Gland Dysfunction

Conducted by Bruce Butts, OD

Meibomian Gland Dysfunction (MGD) stands as the primary culprit behind Evaporative Dry Eye. It is marked by a decrease and/or alteration in meibum secretion, leading to the disturbance of the lipid layer in the tear film and an elevated rate of tear film evaporation. The main treatment for MGD is an Ophthalmic Solution. For this case study Regener-Eyes Ophthalmic Solution was utilized in the treatment of dry eye associated with MGD.
During this independent study 5 patients were monitored over different periods of time to evaluate the effectiveness of Regener-Eyes Ophthalmic Solution in helping relive dry eye associated MGD.
Patient one and two were examined over a 2 month period. Patients three and four were tested over the course of 3 months. While patient five was evaluated at 5 months. Below are before and after images that display the regression of dry eye associated MGD.
VIEW IMAGES

Regener-Eyes® Independent Study: Helping Dry Eye Associated with Neurotrophic Keratopathy Secondary to Sjögren's

Conducted by Kenneth Daniels, OD, FAAO

Patients with neurotrophic keratopathy due to Sjögren's syndrome may experience persistent dryness, discomfort, and an increased risk of corneal infections. Treatment involves addressing the underlying Sjögren's syndrome, using artificial tears for lubrication, and implementing measures to enhance corneal healing. For this case study we are evaluating Regener-Eyes Ophthalmic Solution and its effectiveness in relieving dry eye associated with Neurotrophic Keratopathy Secondary to Sjogren's.
During this independent study 1 patient was monitored over a 7 day period of time to evaluate the effectiveness of Regener-Eyes Ophthalmic Solution in treating dry eye associated with Neurotrophic Keratopathy to Sjogren's. A corneal staining test for dry eye was conducted to examine the results. Below are before and after images that display the regression of dry eye associated with Neurotrophic Keratopathy 2ary to Sjogren's.
VIEW IMAGES

Regener-Eyes® Keratograph: Before and After Images

Provided by South Coast Optometry - Dr. Daniel Quon 

A keratograph is a specialized imaging device used in ophthalmology to examine the cornea, the transparent outer layer of the eye. It provides detailed images of the corneal surface and allows for analysis of various parameters such as tear film and dry eye assessment.
In a keratograph, colors are often used to represent different parameters or conditions, and creating a key to understand these colors is essential for interpreting the images produced by the device.
VIEW KERATOGRAPHS HERE